FOLD Stock UPDATES Amicus Therapeutics (FOLD) 5.87 08/24/2014

New Post Public Reply Private Reply Replies (0) Message Board

Aug 24, 2014 at 11:36 PM

Amicus Therapeutics (FOLD) 5.87 $FOLD

Trade-Ideas: Amicus Therapeutics (FOLD) Is Today's Strong On High Relative Volume Stock
at The Street - Fri Aug 22, 1:14PM CDT
Trade-Ideas LLC identified Amicus Therapeutics (FOLD) as a strong on high relative volume candidate

Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day
PR Newswire - Fri Aug 22, 9:20AM CDT
Zacks Equity Research highlights Epizyme (Nasdaq:EPZM-Free Report) as the Bull of the Day and Panera (Nasdaq

NRA-Free Report) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on Amicus Therapeutics (Nasdaq:FOLD-Free Report), Sanofi (NYSE:SNY-Free Report) and Shire (Nasdaq:SHPG-Free Report).

Amicus Therapeutics (FOLD) Soars on Fabry Drug Trial Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Aug 21, 3:55PM CDT
Amicus Therapeutics (FOLD) announced positive data from its second phase III study on migalastat.

Amicus Therapeutics (FOLD) Worth Watching: Stock Rises 20.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Aug 21, 8:39AM CDT
Amicus Therapeutics, Inc. (FOLD) was a big mover last session, as its shares rose over 20% on the day.

Can the Rally in Amicus Therapeutics (FOLD) Shares Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Aug 21, 8:03AM CDT
Can the Rally in Amicus Therapeutics (FOLD) Shares Continue?

SmarTrend Watching for Potential Pullback in Shares of Amicus Therapeutics After 20.35% Gain
Comtex SmarTrend(R) - Wed Aug 20, 4:00PM CDT
Amicus Therapeutics (NASDAQ:FOLD) traded in a range yesterday that spanned from a low of $5.02 to a high of $5.99. Yesterday, the shares gained 20.4%, which took the trading range above the 3-day high of $4.70 on volume of 33.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Why Amicus Therapeutics (FOLD) Stock Hit a One-Year High Today
at The Street - Wed Aug 20, 9:29AM CDT
Amicus Therapeutics (FOLD) surged to a 52-week high on Wednesday after the company announced its potential Fabry disease treatment drug migalastat met its primary endpoints in a late-stage study.

Why Amicus Therapeutics, Inc. Stock Is Soaring Today
George Budwell, The Motley Fool - Motley Fool - Wed Aug 20, 9:12AM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Amicus Therapeutics , a clinical-stage...

Amicus Therapeutics Has Returned 111.6% Since SmarTrend Recommendation (FOLD)
Comtex SmarTrend(R) - Wed Aug 20, 9:10AM CDT
SmarTrend identified an Uptrend for Amicus Therapeutics (NASDAQ:FOLD) on May 30th, 2014 at $2.42. In approximately 3 months, Amicus Therapeutics has returned 111.57% as of today's recent price of $5.12.

Yes, Call it a Comeback: Amicus Fabry Drug Posts Big Study Win
at The Street - Wed Aug 20, 5:01AM CDT
Based on the positive study results, Amicus intends to seek European approval for migalastat early next year.

Amicus Therapeutics Announces Positive Phase 3 Data From Fabry Monotherapy Study 012
GlobeNewswire - Wed Aug 20, 5:00AM CDT
Migalastat Successfully Meets Both Co-Primary Endpoints of Comparability to Enzyme Replacement Therapy (ERT) on Both Key Measures of Kidney Function

Pre-Market Review on Biotech Equities -- Exelixis, Novavax, Achillion Pharma, XOMA, and Amicus Therapeutics
PR Newswire - Wed Aug 13, 7:50AM CDT
On Tuesday, August 12, 2014, the NASDAQ Composite ended at 4,389.25, down 0.27%, the Dow Jones Industrial Average finished the session at 16,560.54, down 0.06% and the S&P 500 closed at 1,933.75, down 0.16%. During the trading session, seven out of ten sectors finished on a lower note. The S&P 500 Health Care Sector Index ended the day 0.14% lower at 699.06, and the index has declined 1.94% in the previous one month. Investor-Edge has initiated coverage on the following equities: Exelixis Inc. (NASDAQ: EXEL), Novavax Inc. (NASDAQ: NVAX), Achillion Pharmaceuticals Inc. (NASDAQ: ACHN), XOMA Corp. (NASDAQ: XOMA), and Amicus Therapeutics Inc. (NASDAQ: FOLD). Free research on these five companies can be accessed at:

Amicus Therapeutics Announces Second Quarter 2014 Financial Results and Corporate Updates
GlobeNewswire - Thu Aug 07, 3:43PM CDT
Results From Second Phase 3 Fabry Monotherapy Study (Study 012) on Track for 3Q14

Why Amicus Therapeutics (FOLD) Might Surprise This Earnings Season - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Aug 06, 7:44AM CDT
Amicus Therapeutics possess a favorable Zacks Rank and a positive Zacks Earnings ESP

Amicus Therapeutics to Announce Second Quarter 2014 Financial Results on August 7, 2014
GlobeNewswire - Thu Jul 31, 3:00PM CDT
Amicus Therapeutics (Nasdaq:FOLD) today announced a conference call and live audio webcast on Thursday, August 7, 2014 at 5:00 p.m. ET to discuss financial results for the second quarter ended June 30, 2014.

Conference Call Schedules, Publication of Study Results, and Public Offer Pricing - Research Reports on Medivation, Keryx, Amicus, AGTC and Clovis
PR Newswire - Wed Jul 30, 7:50AM CDT
Today, Analysts Review released its research reports regarding Medivation, Inc. (NASDAQ: MDVN), Keryx Biopharmaceuticals Inc. (NASDAQ: KERX), Amicus Therapeutics, Inc. (NASDAQ: FOLD), Applied Genetic Technologies Corporation (NASDAQ: AGTC) and Clovis Oncology, Inc. (NASDAQ: CLVS). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/5255-100free.

Amicus (FOLD) Shares March Higher, Can It Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jul 29, 10:11AM CDT
Amicus (FOLD) Shares March Higher, Can It Continue?

Applied Genetic Technologies Corporation (AGTC) Looks Strong as Stock Surges 15.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jul 28, 7:44AM CDT
Applied Genetic Technologies Corporation (AGTC) was a big mover last session, as the company saw its shares shoot up over 15% on the day.

Agenus Inc. (AGEN) Looks Strong as Stock Surges 11.15% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jul 25, 7:44AM CDT
Agenus Inc. (AGEN) was a big mover last session, as the company saw its shares shoot up over 11% on the day.

Amicus Therapeutics (FOLD) Jumps: Stock Rises 7.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jul 24, 8:39AM CDT
Amicus Therapeutics, Inc. (FOLD) was a big mover last session, as its shares rose over 7% on the day.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Young Visionaries Win Junior Medals at STARMUS VIII

Fresh from the Canary Islands' shores, STARMUS VIII has lifted the veil on two young powerhouses shaping tomorrow—Valeria Corrales and Aneeshwar Kunchala. These two have snagged coveted honors, crowning them as champions of their generation. Igniting Passion for Science and the Environment Valeria Corrales isn't just another face in the crowd; she’s the force behind a...

AI Revenue Missteps Shake Semiconductor Stocks

Nervous Times for Semiconductor Stocks When the semiconductor sector started October like a high-speed train, I thought we might sail through this month without hitting turbulence. But then, in trotted some shaky AI revenue numbers, and bam, the whole sector took a hit off its October highs. The semiconductor stocks, led by giants like Taiwan Semiconductor Manufacturing...

tm:rw Revolutionizes Retail with Live TikTok Studios

tm:rw Takes a Bold Step into Social Commerce Throw out whatever you've thought about traditional brick-and-mortar retail because tm:rw isn't just bending the rules—it's burning the book. Launching nine branded studio spaces at their Times Square flagship, tm:rw is blending live streaming with in-person shopping, all in sync with TikTok Shop. The experience is less about...

Retail Trading Platforms Report Record Growth in 2026

A Boom in Self-Directed Investing Times are changing, folks. More people than ever are taking finance into their own hands, wielding smartphones like fiscal swords in the name of self-directed investment. No middlemen, no fancy office, just straight-up trading from wherever you might be perched. Four major platforms now boast over 41 million funded accounts combined, each...

Buying Land in Greeneville: Avoiding Costly Mistakes

Diving Headfirst into Raw Land Purchases Buying land isn't like your typical house flip in Greeneville, Tennessee. It's a whole different ballgame out there. You might think you're just purchasing a piece of Mother Earth, but you got to know there's more beneath the surface—quite literally—before you sign anything. You can go from a promising adventure to a...

Haag-Streit Debuts Innovative Octopus 910 Perimeter at AAO

Now here's something that'll tickle your ophthalmologist's fancy—Haag-Streit USA has rolled out the Octopus 910, a slick piece of kit set to shake up visual field testing for glaucoma management. This time, they're getting in front of the competition, unveiling it at the Association for Research in Vision and Ophthalmology's 2026 shindig in New Orleans. With this new...

AI in Music: CITY JAM Focuses on Human Creativity

Breaking Down the AI Music Race In the wild world of music production, AI's making waves. Here's the thing though—it's all about how fast and how much it can churn out. Now, won't lie to you, that's impressive, but not the full picture. Pat Villaceran, the brain behind CITY JAM, is adamant that the real gold isn't just speed. It's the unique sound each artist brings to...

RingConn Smart Ring Gains Key FDA 510(k) Clearance

FDA Clearance: A Major Step for RingConn In a space where every tiny gadget-maker is desperately clawing for a regulatory nod, RingConn—a venture born from Shenzhen Ninenovo Technology Limited—has snagged an FDA 510(k) clearance (Clearance No. K260490) for their wearable Smart Ring that measures blood oxygen levels non-invasively. October 10, 2026, marked the day when...

Arrvel's Thermal Printers: Aiming at E-Com Sellers

Arrvel's Thermal Printing Push: An Overview No one would have pegged tiny thermal label printers as game-changers, but here we are. Arrvel's new lineup of thermal printers is shaking up the world for anyone who's ever had to slap on a shipping label or get inventory organized. They're targeting e-commerce folks and small businesses, which sounds like the right move as...

Zoomlion Boosts Mining Gear Amid Global Revenue Surge

An Ambitious Expansion Overhaul Alright, let's talk Zoomlion Heavy Industry Science & Technology Co., Ltd. They're not just making a splash; they're wading knee-deep into expanding their mining machinery operations and taking charge in international markets. You see, in the first half of 2026, this Chinese behemoth saw its mining machinery business skyrocket by over...